Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

An evaluation of risperidone drug interactions.

C L DeVane1, C B Nemeroff

  • 1Department of Psychiatry & Behavioral Sciences, Medical University of South Carolina, Charleston 29425-0742, USA. devanel@musc.edu

Journal of Clinical Psychopharmacology
|July 31, 2001
PubMed
Summary

Risperidone, an atypical antipsychotic, has a low risk of drug interactions. While some medications may alter its levels, clinical significance appears minimal, ensuring safe and effective treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessing in-session rumination and its effects on CBT for depression.

Behaviour research and therapy·2022
Same author

Lifelong outcomes and effects on brain and behavior following childhood maltreatment and early life stress: A primer to inform future research.

Pharmacology, biochemistry, and behavior·2022
Same author

Validity and severity thresholds for the depression subscale of the affective self rating scale: An equipercentile equating study using classical test theory.

Journal of affective disorders·2021
Same author

The revolution of personalized psychiatry: will technology make it happen sooner?

Psychological medicine·2017
Same author

Childhood trauma predicts antidepressant response in adults with major depression: data from the randomized international study to predict optimized treatment for depression.

Translational psychiatry·2016
Same author

Brain activation induced by psychological stress in patients with schizophrenia.

Schizophrenia research·2015

Area of Science:

  • Pharmacology and Psychiatry
  • Drug Metabolism and Interactions

Background:

  • Risperidone is a key atypical antipsychotic for schizophrenia and other disorders.
  • Polypharmacology is common in patients with comorbid conditions.
  • Drug-drug interactions (DDIs) are a concern with multiple concurrent therapies.

Purpose of the Study:

  • To review and evaluate reported drug interactions involving risperidone.
  • To assess the clinical significance of risperidone-related DDIs.
  • To evaluate the potential for risperidone to participate in DDIs based on its pharmacokinetics.

Main Methods:

  • Systematic review of the biomedical literature for risperidone drug interactions.
  • Evaluation of clinical significance of reported interactions.
  • Analysis of risperidone's pharmacokinetic properties to predict interaction potential.

Related Experiment Videos

Main Results:

  • Risperidone demonstrates a low potential for metabolic drug interactions.
  • Inhibition or induction of CYP2D6 and CYP3A4 may affect risperidone plasma concentrations.
  • The clinical significance of these potential interactions appears minimal.

Conclusions:

  • Risperidone is associated with a low risk of clinically significant drug interactions.
  • Adherence to dosage regimen guidelines can mitigate the impact of DDIs.
  • This supports the safe and optimal use of risperidone in polypharmacotherapy.